We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 20

U.S. Supreme Court Myriad decision not expected to affect Australian law-makers

  • Houlihan2
  • -
  • Australia, USA
  • -
  • June 14 2013

The U.S. Supreme Court has this week invalidated Myriad's Patent on isolated DNA of the BRCA-1 gene and its use in their breast cancer diagnostic

US Supreme Court rules isolated DNA lacks patent eligibility

  • Wrays
  • -
  • Australia, USA
  • -
  • June 14 2013

On 13 June 2013, the United States Supreme Court ruled in Association for Molecular Pathology v. Myriad Genetics ("Myriad") that: For the reasons

The US Supreme Court rules on gene patents

  • Shelston IP
  • -
  • Australia, USA
  • -
  • June 14 2013

In its long-awaited landmark decision in the case of Association for Molecular Pathology v. Myriad Genetics Inc., the U.S. Supreme Court has

Pharmaceutical trade marks case law round up for 2012early 2013

  • Corrs Chambers Westgarth
  • -
  • Australia, European Union, USA
  • -
  • June 6 2013

A brief wrap-up of recent decisions relating to trade marks in the pharma space from the EU, the United States and Australia

Did a gene patent save Angelina Jolie's life?

  • Shelston IP
  • -
  • Australia, USA
  • -
  • May 27 2013

The recent news that Angelina Jolie tested positive for the BRCA1 mutation and has consequently undergone a prophylactic double mastectomy to guard

Universities abroad experiment with no-fee licensing to drive biotech partnerships

  • Shook Hardy & Bacon LLP
  • -
  • Australia, Canada, European Union, United Kingdom, USA
  • -
  • May 16 2013

Universities in Australia, Canada, Europe, and the United Kingdom have reportedly embraced a 2010 Glasgow University initiative under which companies

Dispelling the Myriad gene patent harmonization myth

  • Foley & Lardner LLP
  • -
  • Australia, Canada, European Union, France, Germany, Japan, USA
  • -
  • April 30 2013

In the wake of the Supreme Court oral arguments in the Myriad "gene patent" case, most commentators are predicting that the Court will uphold the

Australian Federal Court upholds Myriad’s gene patent

  • Morrison & Foerster LLP
  • -
  • Australia, USA
  • -
  • February 15 2013

While the question of patentability of isolated gene sequences awaits resolution at the U.S. Supreme Court, the Australian Federal Court today upheld

BLG Monthly Update

  • Borden Ladner Gervais LLP
  • -
  • Argentina, Australia, Canada, United Kingdom, USA
  • -
  • December 19 2012

The BLG Monthly Update is a digest of recent developments in the law which Neil Guthrie, our National Director of Research, thinks you will find

Rudd Center study examines obesity-related health messaging

  • Shook Hardy & Bacon LLP
  • -
  • Australia, United Kingdom, USA
  • -
  • September 14 2012

Researchers with Yale University’s Rudd Center for Food Policy and Obesity have published a study purportedly assessing the effectiveness of “major obesity public health campaigns from the United States, the United Kingdom and Australia.”

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy